Evidence map›Paper›PMID 33867389›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Neuromyelitis Optica Complicated by Ornithine Transcarbamylase Deficiency Treated Safely with Pulse Steroid Therapy.

Ryuto Yoshida, Takuya Sasaki, Takashi Sunouchi, Masayuki Ueda, Mizuki Kitamura, Takahiro Nakayama, Jun Saito, Ichiro Imafuku

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ryuto YoshidaDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Takuya SasakiDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Takashi SunouchiDepartment of Endocrinology and Metabolism, Yokohama Rosai Hospital, Japan.
Masayuki UedaDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Mizuki KitamuraDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Takahiro NakayamaDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Jun SaitoDepartment of Endocrinology and Metabolism, Yokohama Rosai Hospital, Japan.
Ichiro ImafukuDepartment of Neurology, Yokohama Rosai Hospital, Japan.
Yokohama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroid administration to patients with urea cycle disorders can cause hyperammonemia. We encountered a 36-year-old woman with neuromyelitis optica (NMO) complicated by ornithine transcarbamylase (OTC) deficiency. By reducing the doses of steroids and adequate infusion management, we were able to administer pulse steroid therapy without any severe complications. This case indicates the safety of steroid treatment in patients with urea cycle disorders.

Indexed as

HyperammonemiaNeuromyelitis OpticaOrnithine Carbamoyltransferase Deficiency DiseaseAdultEatingFemaleHumansneuromyelitis opticaornithine transcarbamylase deficiencypulse steroid therapyurea cycle disorders

Identifiers

PMID33867389
PMCPMC8580751
OpenAlexW3156911226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.